JenLab GmbH

About:

JenLab GmbH provides femtosecond laser technology for medicine, biotechnology and cell biology use.

Top Investors: EASME - EU Executive Agency for SMEs

Description:

JenLab GmbH provides femtosecond laser technology for medicine, biotechnology and cell biology use. Clinical in vivo optical biopsies with subcellular spatial resolution and chemical information based on near infrared femtosecond laser technology can be obtained with the CE marked Multiphoton Tomographs DermaInspect, the SPIE Prism awarded MPTflex and MPTflex CARS.

Total Funding Amount:

2.48M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Neuengönna, Thuringen, Germany

Founded Date:

1999-01-01

Founders:

Karsten König

Number of Employees:

1-10

Last Funding Date:

2016-09-01

IPO Status:

Private

Industries: